-- ============================================================================
-- SURGERY 3 MCQ BATCH 31: Small Bowel Disorders (Questions 1801-1860)
-- Topic: Small Bowel Tumors, Crohn's Disease Surgery, Mesenteric Ischemia
-- ============================================================================

INSERT INTO questions (topic_id, category_id, question_text, option_a, option_b, option_c, option_d, option_e, correct_option, explanation, difficulty, cognitive_level) VALUES

-- Small Bowel Tumors (1-20)
('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Small bowel tumors account for what percentage of all gastrointestinal malignancies:',
'25%', 'Approximately 3-5% despite the small bowel comprising 75% of GI tract length', '50%', '75%', '90%',
'B', 'Small bowel tumors: rare, only 3-5% of all GI malignancies despite small bowel being 75% of GI tract length and 90% of mucosal surface. Theories for rarity: rapid transit (less carcinogen exposure), liquid content, lower bacterial load, high IgA, dilution of carcinogens, more rapid cell turnover. Reference: Bilimoria KY. Ann Surg Oncol. 2009.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'The most common malignant tumor of the small bowel is:',
'Leiomyosarcoma', 'Adenocarcinoma (40%), followed closely by neuroendocrine tumors (carcinoid)', 'Lymphoma only', 'Lipoma', 'Hemangioma',
'B', 'Small bowel malignancies: (1) Adenocarcinoma (40%) - most common, usually duodenum/proximal jejunum. (2) Neuroendocrine tumors (carcinoid, 35-40%) - most common in ileum. (3) Lymphoma (15%) - usually non-Hodgkin B-cell. (4) GIST (10%). Adenocarcinoma associated with Crohn disease, celiac disease, FAP, Lynch syndrome. Reference: Bilimoria KY. Ann Surg Oncol. 2009.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Small bowel adenocarcinoma most commonly occurs in:',
'Terminal ileum', 'Duodenum (especially periampullary region), followed by proximal jejunum', 'Appendix', 'Colon', 'Rectum',
'B', 'Small bowel adenocarcinoma location: duodenum (55-80%), jejunum (15-25%), ileum (10-15%). Periampullary region most common site. Risk factors: Crohn disease (ileum), celiac disease (jejunum - must rule out in unexplained adenocarcinoma), FAP (duodenum - especially ampullary), Lynch syndrome, Peutz-Jeghers. Reference: Aparicio T. Gastroenterol Clin Biol. 2005.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Small bowel neuroendocrine tumors (carcinoid) most commonly arise in:',
'Duodenum', 'Ileum (terminal ileum most common location for GI carcinoid)', 'Jejunum', 'Stomach', 'Rectum',
'B', 'Small bowel NETs/carcinoid: most common site for GI carcinoid is ileum (especially distal/terminal ileum). Often multiple (30%). Arise from enterochromaffin cells, produce serotonin. Associated with carcinoid syndrome (flushing, diarrhea, wheezing, right-sided valvular heart disease) when liver metastases present (bypass hepatic metabolism). Diagnosis: chromogranin A, 5-HIAA. Treatment: surgical resection with mesenteric lymphadenectomy. Reference: Modlin IM. Lancet Oncol. 2008.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Carcinoid syndrome occurs when:',
'In all carcinoid tumors', 'Liver metastases are present, allowing serotonin and other vasoactive substances to bypass hepatic metabolism', 'Only with appendiceal carcinoid', 'With primary tumor only', 'In early disease',
'B', 'Carcinoid syndrome: occurs with liver metastases (or extensive retroperitoneal/ovarian disease with systemic venous drainage). Primary small bowel tumors: serotonin metabolized by liver (first-pass metabolism). Liver metastases: serotonin enters systemic circulation. Symptoms: flushing (episodic), diarrhea (secretory), wheezing (bronchoconstriction), right-sided heart disease (tricuspid regurgitation, pulmonary stenosis - serotonin fibrosis). Diagnosis: 24-hour urine 5-HIAA, chromogranin A. Treatment: somatostatin analogs (octreotide). Reference: Modlin IM. Lancet Oncol. 2008.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Treatment of small bowel carcinoid tumor includes:',
'Observation only', 'Surgical resection with wide mesenteric margins and lymphadenectomy, even with liver metastases', 'Chemotherapy only', 'Radiation only', 'No treatment',
'B', 'Small bowel carcinoid treatment: Surgery primary treatment. Wide segmental resection with mesenteric lymphadenectomy (lymph node metastases common, fibrotic mesenteric reaction). Debulking of liver metastases if >90% can be removed (symptom control). Even with metastases, resection improves survival and symptoms. Medical: somatostatin analogs (octreotide, lanreotide) for carcinoid syndrome and tumor growth control. Peptide receptor radionuclide therapy (PRRT) with lutetium-177. Chemotherapy less effective. Reference: Howe JR. J Am Coll Surg. 2006.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Meckel diverticulum is:',
'An acquired diverticulum', 'A true diverticulum (all bowel wall layers) on antimesenteric border of ileum, remnant of omphalomesenteric duct', 'A false diverticulum', 'Located in jejunum', 'On mesenteric border',
'B', 'Meckel diverticulum: Rule of 2s - 2% of population, 2 feet from ileocecal valve, 2 inches long, symptomatic by age 2, 2 types of ectopic mucosa (gastric, pancreatic). Persistence of omphalomesenteric (vitelline) duct. True diverticulum (all layers), antimesenteric border. Complications: bleeding (ectopic gastric mucosa → ulceration of adjacent ileum), obstruction (intussusception, volvulus, hernia - Littre), diverticulitis (mimics appendicitis). Reference: Sagar J. J R Soc Med. 2006.',
'easy', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Diagnosis of symptomatic Meckel diverticulum in children is best made with:',
'CT scan', 'Technetium-99m pertechnetate scan (Meckel scan) detecting ectopic gastric mucosa', 'Upper GI series', 'Colonoscopy', 'MRI',
'B', 'Meckel scan (Tc-99m pertechnetate scintigraphy): pertechnetate taken up by parietal cells of gastric mucosa (including ectopic gastric tissue in Meckel diverticulum). Sensitivity 80-90% in children, lower in adults (less gastric mucosa). Best for pediatric GI bleeding from Meckel. False negatives: no gastric mucosa, poor uptake. H2 blockers may enhance uptake. CT/small bowel follow-through less sensitive. Negative scan does not exclude Meckel if high suspicion. Reference: Sagar J. J R Soc Med. 2006.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Incidental Meckel diverticulum found at surgery should be:',
'Always resected', 'Resected if young (<40-50), abnormal appearance, or narrow neck; otherwise debatable', 'Never resected', 'Biopsied only', 'Left alone always',
'B', 'Incidental Meckel resection: controversial. Arguments for: prevents future complications (bleeding, obstruction, diverticulitis). Arguments against: low lifetime complication rate (4%), surgical morbidity. Resection generally recommended if: (1) Age <40-50 (higher complication rate in young), (2) Abnormal appearance (thickened, palpable heterotopic tissue), (3) Narrow neck (obstruction risk), (4) Male (higher complication rate). If normal-appearing in older adult during uncomplicated procedure - may leave. Reference: Zani A. J Am Coll Surg. 2008.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Primary small bowel lymphoma is most commonly which type:',
'Hodgkin lymphoma', 'Non-Hodgkin B-cell lymphoma (DLBCL most common)', 'T-cell lymphoma only', 'Mantle cell only', 'Burkitt only',
'B', 'Small bowel lymphoma: primary GI lymphoma, small bowel second most common site after stomach. Types: (1) Diffuse large B-cell lymphoma (DLBCL, most common), (2) Immunoproliferative small intestinal disease (IPSID/Mediterranean lymphoma - alpha heavy chain), (3) Enteropathy-associated T-cell lymphoma (EATL - complicates celiac disease), (4) Mantle cell lymphomatous polyposis, (5) Follicular lymphoma, (6) Burkitt lymphoma. Treatment: chemotherapy primary (CHOP), surgery for complications (perforation, bleeding, obstruction). Reference: Ghimire P. World J Gastrointest Oncol. 2011.',
'medium', 'knowledge'),

-- Crohn's Disease Surgical Management (21-35)
('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Surgical indications in Crohn disease include:',
'All Crohn patients need surgery', 'Failure of medical therapy, obstruction, fistula, abscess, perforation, hemorrhage, or malignancy', 'Early disease only', 'Never indicated', 'Only for colonic disease',
'B', 'Crohn disease surgery indications: (1) Failure of medical therapy (refractory symptoms despite optimized medications), (2) Complications - stricture/obstruction (most common surgical indication), fistula (enterocutaneous, enteroenteric, enterovesical, enterovaginal), abscess, perforation, hemorrhage, (3) Dysplasia/cancer, (4) Growth retardation in children, (5) Medication intolerance/side effects. 70-80% require surgery in lifetime. NOT curative - recurrence common (50% at 10 years). Reference: Simillis C. Aliment Pharmacol Ther. 2007.',
'easy', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'The surgical principle "bowel-sparing" in Crohn disease refers to:',
'Removing all diseased bowel', 'Performing limited resections with minimal margins to preserve bowel length and prevent short bowel syndrome', 'Total colectomy', 'Extensive resection', 'No surgery',
'B', 'Bowel-sparing surgery: fundamental principle in Crohn disease. Rationale: (1) Crohn is pan-intestinal disease, surgery not curative, (2) Multiple surgeries likely over lifetime, (3) Short bowel syndrome (SBS) is devastating complication. Approach: (1) Limited resections - remove only grossly diseased bowel causing symptoms, (2) Minimal margins (2-3 cm) - wider margins do not reduce recurrence, (3) Strictureplasty - preserves bowel for fibrostenotic disease. Reference: Bernell O. Ann Surg. 2000.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Strictureplasty in Crohn disease is indicated for:',
'All strictures', 'Fibrostenotic (non-inflammatory) strictures where bowel preservation is important', 'Inflammatory strictures', 'Fistulizing disease', 'Malignancy',
'B', 'Strictureplasty: bowel-preserving technique for fibrostenotic Crohn strictures. Indications: (1) Multiple strictures (would require extensive resection), (2) Previous significant resection (SBS risk), (3) Fibrostenotic (fibrotic) strictures - not actively inflamed. Contraindications: (1) Fistula at stricture, (2) Actively inflamed bowel, (3) Malignancy/dysplasia, (4) Malnutrition/sepsis, (5) Long strictures (>20cm). Techniques: Heineke-Mikulicz (short <10cm), Finney (10-20cm), side-to-side isoperistaltic (>20cm). Reference: Yamamoto T. Dis Colon Rectum. 2007.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Crohn disease recurrence after ileocolic resection most commonly occurs at:',
'Distant bowel', 'The neoterminal ileum (proximal to ileocolic anastomosis)', 'Rectum', 'Stomach', 'Esophagus',
'B', 'Crohn recurrence after ileocolic resection: characteristically at neoterminal ileum (just proximal to anastomosis). Endoscopic recurrence: 70-90% at 1 year. Clinical recurrence: 30% at 5 years, 50% at 10 years. Risk factors for recurrence: smoking (most important modifiable), perforating/fistulizing phenotype, extensive small bowel disease, previous resections. Prevention: smoking cessation, postoperative prophylaxis (azathioprine, biologics), endoscopic monitoring. Reference: Bernell O. Ann Surg. 2000.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Management of intra-abdominal abscess in Crohn disease includes:',
'Immediate surgery always', 'Percutaneous drainage with antibiotics, nutrition optimization, then delayed surgery if needed', 'Antibiotics only', 'Observation', 'No treatment',
'B', 'Crohn abscess management: (1) Percutaneous CT-guided drainage (most abscesses) + IV antibiotics, (2) Nutritional optimization (TPN if necessary), (3) Immunosuppression held temporarily, (4) Once abscess resolved (weeks), elective resection if indicated. Immediate surgery: if percutaneous not feasible, failed drainage, free perforation with peritonitis, obstruction. Staged approach reduces morbidity, allows single-stage resection with primary anastomosis, improves nutritional status. Reference: Feagins LA. Gastroenterology. 2017.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Enterovesical fistula in Crohn disease typically presents with:',
'Painless bleeding', 'Pneumaturia (air in urine), fecaluria, and recurrent urinary tract infections', 'Diarrhea only', 'Constipation', 'Weight gain',
'B', 'Enterovesical fistula: communication between bowel (usually terminal ileum or sigmoid colon) and bladder. Presentation: (1) Pneumaturia (most specific - air passage during/after urination), (2) Fecaluria (particles in urine), (3) Recurrent UTIs (polymicrobial, E. coli, Klebsiella), (4) Dysuria, frequency, suprapubic pain. Diagnosis: CT (air in bladder, fistula tract), cystoscopy (inflammation), cystogram. Treatment: segmental bowel resection with primary anastomosis, bladder repair if needed. Reference: Fazio VW. Surg Clin North Am. 2001.',
'easy', 'knowledge'),

-- Mesenteric Ischemia (36-55)
('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Acute mesenteric ischemia is most commonly caused by:',
'Venous thrombosis', 'Superior mesenteric artery embolism (50%), usually from cardiac source', 'Aortic dissection', 'Trauma', 'Compression',
'B', 'Acute mesenteric ischemia causes: (1) SMA embolism (50%) - cardiac source (atrial fibrillation, MI, valve disease), lodges at branch point 3-6 cm from origin (beyond middle colic artery), (2) SMA thrombosis (25%) - atherosclerosis at origin, chronic stenosis, (3) Non-occlusive mesenteric ischemia (NOMI, 20%) - low-flow state (shock, heart failure), mesenteric vasoconstriction, (4) Mesenteric venous thrombosis (5%) - hypercoagulable states. SMA most affected (supplies midgut). Reference: Oldenburg WA. Arch Intern Med. 2004.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'The classic presentation of acute mesenteric ischemia is:',
'Painless diarrhea', 'Severe abdominal pain "out of proportion" to physical examination findings, often with history of atrial fibrillation', 'Gradual onset pain', 'Constipation only', 'Fever first',
'B', 'Acute mesenteric ischemia presentation: "Pain out of proportion to examination" - severe periumbilical/diffuse pain initially with minimal findings (gut dying but not yet necrotic). Rapid, acute onset. History: atrial fibrillation (embolic source), cardiovascular disease, heart failure, recent MI. Progression: bloody diarrhea, peritonitis (late - bowel necrosis), shock. Mortality 60-80% (high due to delayed diagnosis, advanced disease). Reference: Oldenburg WA. Arch Intern Med. 2004.',
'easy', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'The best initial imaging study for suspected acute mesenteric ischemia is:',
'Plain abdominal X-ray', 'CT angiography (CTA) of the abdomen', 'Ultrasound', 'MRI', 'Barium study',
'B', 'CT angiography (CTA): gold standard for acute mesenteric ischemia diagnosis. Findings: (1) Arterial/venous thrombosis or embolism, (2) Bowel wall thickening, (3) Bowel wall enhancement pattern (decreased or absent in ischemia), (4) Pneumatosis intestinalis (intramural gas - advanced), (5) Portal venous gas (late, poor prognosis), (6) Mesenteric stranding, free fluid. Sensitivity >90%, specificity >95%. Plain films: often normal early, late findings (thumbprinting, pneumatosis, free air). Reference: Wyers MC. J Vasc Surg. 2010.',
'easy', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Management of acute SMA embolism includes:',
'Conservative management', 'Systemic anticoagulation, revascularization (open embolectomy or endovascular), and resection of necrotic bowel', 'Antibiotics only', 'TPN only', 'Observation',
'B', 'Acute SMA embolism treatment: (1) Resuscitation (fluids, correct acidosis), (2) Broad-spectrum antibiotics, (3) Systemic anticoagulation (heparin - prevent propagation), (4) Emergent revascularization - open SMA embolectomy (Fogarty catheter via transverse arteriotomy) or endovascular therapy (catheter-directed thrombolysis, aspiration thrombectomy, stenting). (5) Assess bowel viability, resect necrotic bowel. (6) Second-look laparotomy at 24-48 hours (reassess marginal bowel). Time is bowel - rapid intervention essential. Reference: Acosta S. Br J Surg. 2014.',
'hard', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Non-occlusive mesenteric ischemia (NOMI) occurs in setting of:',
'Atrial fibrillation', 'Low cardiac output states (cardiogenic shock, sepsis) with mesenteric vasoconstriction', 'Healthy patients', 'Trauma only', 'Venous thrombosis',
'B', 'NOMI: ischemia without arterial/venous occlusion. Mechanism: low-flow state + mesenteric vasoconstriction (redistribution of blood to vital organs). Risk factors: (1) Cardiogenic shock, (2) Septic shock, (3) Cardiac surgery (especially after cardiopulmonary bypass), (4) Dialysis with hypotension, (5) Vasopressor use (mesenteric vasoconstriction). Angiography: "pruning," diffuse vasoconstriction. Treatment: treat underlying cause, correct hypotension, intra-arterial vasodilators (papaverine), avoid vasoconstrictors if possible. Reference: Trompeter M. Eur Radiol. 2002.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Mesenteric venous thrombosis is associated with:',
'Atrial fibrillation', 'Hypercoagulable states (malignancy, factor V Leiden, protein C/S deficiency), portal hypertension, and abdominal inflammation', 'Healthy individuals', 'Diet only', 'Exercise',
'B', 'Mesenteric venous thrombosis causes: (1) Hypercoagulable states (50%) - malignancy, polycythemia vera, protein C/S deficiency, antithrombin III deficiency, factor V Leiden, antiphospholipid syndrome. (2) Portal hypertension, (3) Intra-abdominal inflammation (pancreatitis, diverticulitis, appendicitis), (4) Postoperative (abdominal surgery), (5) Oral contraceptives. Presentation: more insidious than arterial (days), abdominal pain, nausea, diarrhea. Diagnosis: CT with contrast (filling defect in SMV/PV). Treatment: anticoagulation (if no bowel necrosis), surgery if necrosis/peritonitis. Reference: Singal AK. J Clin Gastroenterol. 2013.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Chronic mesenteric ischemia (intestinal angina) typically presents with:',
'Acute severe pain', 'Postprandial abdominal pain ("food fear"), weight loss, and sitophobia (fear of eating)', 'Painless diarrhea', 'Constipation', 'No symptoms',
'B', 'Chronic mesenteric ischemia: "intestinal angina." Presentation: (1) Postprandial pain (increased oxygen demand exceeds supply - like cardiac angina with exercise), occurs 15-30 min after meals, lasts 1-3 hours, (2) Weight loss (significant - sitophobia leads to caloric restriction), (3) Sitophobia (fear of eating). Usually requires stenosis of 2+ mesenteric vessels (collaterals). Diagnosis: CTA or MRA. Treatment: revascularization (endovascular - angioplasty/stenting, or open bypass) once diagnosed. Reference: Kolkman JJ. Best Pract Res Clin Gastroenterol. 2017.',
'easy', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Second-look laparotomy after mesenteric revascularization is performed to:',
'Take additional biopsies', 'Reassess bowel viability at 24-48 hours and resect any additional necrotic bowel', 'Close the abdomen', 'Place feeding tube', 'Perform colostomy',
'B', 'Second-look laparotomy: planned reexploration at 24-48 hours after initial operation for acute mesenteric ischemia. Purpose: reassess bowel viability (marginal bowel may declare itself necrotic or viable with reperfusion), resect additional necrotic bowel if needed, perform anastomosis if bowel viable. Reduces mortality, prevents short bowel syndrome from overzealous initial resection. Performed in patients with marginal bowel viability at initial operation. Reference: Wyers MC. J Vasc Surg. 2010.',
'medium', 'knowledge'),

-- Short Bowel Syndrome and Miscellaneous (56-60)
('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Short bowel syndrome (SBS) is defined as:',
'Any bowel resection', 'Inadequate bowel length (<200 cm) or function to maintain nutrition without supplemental support', 'Only in infants', 'Temporary condition', 'Always requires transplant',
'B', 'Short bowel syndrome: malabsorptive state from extensive small bowel resection or dysfunction. Definition: <200 cm small bowel, or functional equivalent. Critical length: generally <100-150 cm without colon (need TPN), <60-75 cm with colon in continuity. Causes: mesenteric ischemia (adults), midgut volvulus/NEC (neonates), Crohn disease, trauma, radiation enteritis. Consequences: malnutrition, dehydration, electrolyte abnormalities, vitamin deficiencies. Management: TPN initially, intestinal adaptation (2-3 years), GLP-2 analogs (teduglutide), surgery (lengthening procedures, transplant). Reference: Kelly DG. Gastroenterology. 2015.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Intestinal adaptation after massive bowel resection involves:',
'Decreased absorption', 'Structural and functional changes (villous hypertrophy, crypt hyperplasia) increasing absorptive capacity', 'Bowel regrowth to original length', 'Immediate recovery', 'No adaptation',
'B', 'Intestinal adaptation: compensatory process after massive resection. Structural changes: (1) Villous hypertrophy (increased height), (2) Crypt hyperplasia, (3) Bowel dilatation and lengthening. Functional changes: increased absorptive capacity per unit length. Factors: enteral nutrition (stimulates adaptation), luminal nutrients, bile salts, pancreatic secretions, hormones (GLP-2, GH). Timeline: begins days after resection, continues for 2-3 years. Ileum adapts better than jejunum. Colon also adapts (absorbs water, SCFAs). Reference: Tappenden KA. J Parenter Enteral Nutr. 2014.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Radiation enteritis is characterized by:',
'Only acute symptoms', 'Acute (during/immediately after radiation) and chronic (months to years later) phases, with chronic causing strictures, fistulas, and malabsorption', 'No chronic effects', 'Always requires surgery', 'Reversible always',
'B', 'Radiation enteritis: GI injury from radiation therapy. Acute (during treatment): self-limited, mucosal inflammation, nausea, diarrhea, abdominal pain. Usually resolves weeks after radiation ends. Chronic (months to years later - 5-15% of patients): obliterative endarteritis → ischemia, fibrosis. Manifestations: strictures (obstruction), fistulas, perforation, malabsorption, bleeding. Treatment: symptomatic, nutritional support, surgery for complications (difficult - friable, poorly healing tissue, try to operate on non-irradiated bowel). Prevention: modern techniques (IMRT), dose limits. Reference: Hauer-Jensen M. Gastroenterology. 2014.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Superior mesenteric artery syndrome (Wilkie syndrome) is caused by:',
'Arterial thrombosis', 'Compression of third part of duodenum between SMA and aorta, often after significant weight loss', 'Venous obstruction', 'Tumor compression', 'Inflammatory stricture',
'B', 'SMA syndrome (Wilkie syndrome, Cast syndrome): extrinsic compression of third part of duodenum between SMA anteriorly and aorta/vertebral column posteriorly. Aortomesenteric angle narrowed (<25° vs normal 38-65°). Risk factors: rapid weight loss (loss of retroperitoneal fat cushion), body casts, scoliosis surgery (hyperextension), eating disorders. Presentation: postprandial vomiting, abdominal distention, weight loss, relief in prone/left lateral position. Diagnosis: UGI shows abrupt cutoff D3, CTA shows narrowed angle. Treatment: conservative (weight gain, feeding tube past obstruction), surgery if refractory (duodenojejunostomy). Reference: Welsch T. J Gastrointest Surg. 2007.',
'medium', 'knowledge'),

('c0000046-0000-0000-0000-000000000046', 'a0000003-0000-0000-0000-000000000003',
'Small bowel obstruction from adhesions is best managed initially with:',
'Immediate surgery for all', 'Conservative management (NGT decompression, IV fluids, NPO) with close monitoring for 24-72 hours if no signs of strangulation', 'Antibiotics only', 'Observation at home', 'TPN only',
'B', 'Adhesive SBO management: Non-operative trial successful in 60-80% of partial SBO. Initial management: (1) NPO, (2) NGT decompression (relieves distention, reduces vomiting), (3) IV fluids (correct dehydration, electrolytes), (4) Foley catheter (monitor output). Close monitoring for strangulation signs. Trial period: 24-72 hours (most resolve within 24-48 hours). Water-soluble contrast (Gastrografin) - therapeutic (osmotic) and diagnostic (predicts need for surgery). Surgery if: complete obstruction, strangulation (fever, tachycardia, peritonitis, leukocytosis, acidosis), no improvement, closed-loop. Reference: Maung AA. J Trauma Acute Care Surg. 2012.',
'medium', 'knowledge');

SELECT 'Surgery 3 MCQ Batch 31 (Small Bowel Disorders): 60 questions inserted' as status;
